Immediate Impact
3 from Science/Nature 54 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of P. Cruaud being referenced
Prolonged paradoxical response to anti-tuberculous treatment after infliximab
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| P. Cruaud | 388 | 276 | 212 | 40 | 581 | |
| Juan C. Sarria | 282 | 218 | 151 | 50 | 651 | |
| J. Maugein | 269 | 349 | 110 | 39 | 649 | |
| Tzou Yien Lin | 269 | 321 | 150 | 38 | 731 | |
| Ning‐Chi Wang | 296 | 276 | 96 | 47 | 622 | |
| Sheng‐Hsiang Lin | 228 | 282 | 131 | 62 | 650 | |
| Nahed Abdel‐Haq | 290 | 301 | 155 | 50 | 713 | |
| Thomas Fekete | 235 | 205 | 101 | 39 | 582 | |
| Dilara Öğünç | 267 | 295 | 76 | 81 | 738 | |
| Pei‐Chun Chan | 254 | 221 | 135 | 37 | 571 | |
| S. de Marie | 333 | 277 | 198 | 22 | 706 |
All Works
Loading papers...